APGE
Apogee Therapeutics, Inc.$134.25+0.28 (+0.21%)Prev Close$133.96·MCap$8.25B·P/E—·Vol525.6K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
35
$39.96M
◆
Net Activity
Net Seller
$39.96M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Apogee Therapeutics, Inc. (APGE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 35 insider sales totaling $39.96M. The most recent insider transaction was by HENDERSON MICHAEL THOMAS (director, officer: Chief Executive Officer), who sold $2.67M worth of shares on Jul 10, 2026. Apogee Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.25B.
APGE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $133.63 | $2.67M | 995,987 |
| Jul 2, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $132.74 | $730.1K | 177,873 |
| Jun 24, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 26,400 | $132.60 | $3.50M | 179,248 |
| Jun 24, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 80,000 | $132.54 | $10.60M | 1,015,987 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $83.38 | $1.67M | 1,109,217 |
| Jun 5, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $78.71 | $432.9K | 205,648 |
| May 15, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $82.09 | $1.64M | 1,117,328 |
| May 8, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $84.14 | $462.8K | 208,823 |
| May 4, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $82.04 | $164.1K | 174,560 |
| Apr 17, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $90.00 | $180.0K | 175,371 |
| Apr 10, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $82.58 | $1.65M | 1,135,187 |
| Apr 3, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $84.84 | $466.6K | 211,200 |
| Apr 3, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $85.01 | $170.0K | 178,471 |
| Mar 27, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $85.00 | $170.0K | 179,371 |
| Mar 13, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $74.78 | $1.50M | 1,164,624 |
| Mar 6, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $71.06 | $390.8K | 212,048 |
| Feb 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $63.35 | $1.27M | 0 |
| Feb 4, 2026 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $65.79 | $361.9K | 0 |
| Feb 2, 2026 | Henderson Jane | Chief Financial Officer | Sell | 2,000 | $65.81 | $131.6K | 0 |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $81.11 | $1.62M | 0 |
| Jan 7, 2026 | Dambkowski Carl | Chief Medical Officer | Sell | 18,700 | $77.84 | $1.46M | 0 |
| Jan 2, 2026 | Henderson Jane | Chief Financial Officer | Sell | 8,000 | $76.14 | $609.1K | 0 |
| Dec 19, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $80.00 | $120.0K | 0 |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $75.38 | $1.51M | 0 |
| Dec 4, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,900 | $75.00 | $817.5K | 0 |
| Dec 4, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $75.00 | $112.5K | 0 |
| Dec 4, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 40,000 | $75.01 | $3.00M | 0 |
| Nov 25, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $70.00 | $105.0K | 0 |
| Nov 14, 2025 | Henderson Jane | Chief Financial Officer | Sell | 2,000 | $65.00 | $130.0K | 0 |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $63.01 | $1.26M | 0 |
| Nov 11, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,000 | $60.00 | $60.0K | 0 |
| Nov 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,785 | $55.07 | $593.9K | 0 |
| Oct 1, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 5,110 | $39.80 | $203.4K | 0 |
| Sep 3, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $37.87 | $103.2K | 0 |
| Aug 6, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $37.78 | $103.0K | 0 |
| Jul 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,090 | $45.09 | $455.0K | 0 |
| Jun 4, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $36.96 | $100.7K | 0 |
| May 7, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $35.75 | $97.4K | 0 |
| Apr 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 3,860 | $36.22 | $139.8K | 0 |
| Mar 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 1,590 | $30.48 | $48.5K | 0 |
| Mar 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 10,000 | $30.15 | $301.5K | 0 |
| Feb 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 3,520 | $40.69 | $143.2K | 0 |
| Feb 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $40.58 | $608.7K | 0 |
| Jan 8, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $48.85 | $732.7K | 0 |
| Jan 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 4,085 | $46.94 | $191.7K | 0 |
| Dec 12, 2024 | McKenna Mark C. | Director | Buy | 20,000 | $49.54 | $990.8K | 0 |
| Dec 11, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 4,540 | $48.76 | $221.4K | 0 |
| Dec 4, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 6,665 | $46.07 | $307.1K | 0 |
| Dec 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $46.58 | $698.7K | 0 |
| Nov 6, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 6,665 | $59.12 | $394.0K | 0 |
Showing 1–50 of 61
1 / 2
APGE Insider Buying Activity
The following table shows recent insider purchases of Apogee Therapeutics, Inc. (APGE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | McKenna Mark C. | Director | Buy | 20,000 | $49.54 | $990.8K | 0 |
APGE Insider Selling Activity
The following table shows recent insider sales of Apogee Therapeutics, Inc. (APGE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $133.63 | $2.67M | 995,987 |
| Jul 2, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $132.74 | $730.1K | 177,873 |
| Jun 24, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 26,400 | $132.60 | $3.50M | 179,248 |
| Jun 24, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 80,000 | $132.54 | $10.60M | 1,015,987 |
| Jun 12, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $83.38 | $1.67M | 1,109,217 |
| Jun 5, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $78.71 | $432.9K | 205,648 |
| May 15, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $82.09 | $1.64M | 1,117,328 |
| May 8, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $84.14 | $462.8K | 208,823 |
| May 4, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $82.04 | $164.1K | 174,560 |
| Apr 17, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $90.00 | $180.0K | 175,371 |
| Apr 10, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $82.58 | $1.65M | 1,135,187 |
| Apr 3, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $84.84 | $466.6K | 211,200 |
| Apr 3, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $85.01 | $170.0K | 178,471 |
| Mar 27, 2026 | Henderson Jane | officer: Chief Financial Officer | Sell | 2,000 | $85.00 | $170.0K | 179,371 |
| Mar 13, 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $74.78 | $1.50M | 1,164,624 |
| Mar 6, 2026 | Dambkowski Carl | officer: Chief Medical Officer | Sell | 5,500 | $71.06 | $390.8K | 212,048 |
| Feb 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $63.35 | $1.27M | 0 |
| Feb 4, 2026 | Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $65.79 | $361.9K | 0 |
| Feb 2, 2026 | Henderson Jane | Chief Financial Officer | Sell | 2,000 | $65.81 | $131.6K | 0 |
| Jan 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $81.11 | $1.62M | 0 |
| Jan 7, 2026 | Dambkowski Carl | Chief Medical Officer | Sell | 18,700 | $77.84 | $1.46M | 0 |
| Jan 2, 2026 | Henderson Jane | Chief Financial Officer | Sell | 8,000 | $76.14 | $609.1K | 0 |
| Dec 19, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $80.00 | $120.0K | 0 |
| Dec 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $75.38 | $1.51M | 0 |
| Dec 4, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,900 | $75.00 | $817.5K | 0 |
| Dec 4, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $75.00 | $112.5K | 0 |
| Dec 4, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 40,000 | $75.01 | $3.00M | 0 |
| Nov 25, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,500 | $70.00 | $105.0K | 0 |
| Nov 14, 2025 | Henderson Jane | Chief Financial Officer | Sell | 2,000 | $65.00 | $130.0K | 0 |
| Nov 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 20,000 | $63.01 | $1.26M | 0 |
| Nov 11, 2025 | Henderson Jane | Chief Financial Officer | Sell | 1,000 | $60.00 | $60.0K | 0 |
| Nov 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,785 | $55.07 | $593.9K | 0 |
| Oct 1, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 5,110 | $39.80 | $203.4K | 0 |
| Sep 3, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $37.87 | $103.2K | 0 |
| Aug 6, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $37.78 | $103.0K | 0 |
| Jul 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 10,090 | $45.09 | $455.0K | 0 |
| Jun 4, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $36.96 | $100.7K | 0 |
| May 7, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 2,725 | $35.75 | $97.4K | 0 |
| Apr 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 3,860 | $36.22 | $139.8K | 0 |
| Mar 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 1,590 | $30.48 | $48.5K | 0 |
| Mar 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 10,000 | $30.15 | $301.5K | 0 |
| Feb 5, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 3,520 | $40.69 | $143.2K | 0 |
| Feb 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $40.58 | $608.7K | 0 |
| Jan 8, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $48.85 | $732.7K | 0 |
| Jan 2, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | 4,085 | $46.94 | $191.7K | 0 |
| Dec 11, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 4,540 | $48.76 | $221.4K | 0 |
| Dec 4, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 6,665 | $46.07 | $307.1K | 0 |
| Dec 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | 15,000 | $46.58 | $698.7K | 0 |
| Nov 6, 2024 | Dambkowski Carl | Chief Medical Officer | Sell | 6,665 | $59.12 | $394.0K | 0 |
APGE Insiders
HENDERSON MICHAEL THOMAS
director, officer: Chief Executive Officer
Sold $37.96M
20 tradesLast: Jul 10, 2026
Similar Stocks to APGE
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B